Related by context. All words. (Click for frequent words.) 52 postapproval 52 postmarket surveillance 52 Premarket Approval 50 enoxaparin sodium injection 50 postmarketing studies 50 Nabi HB Intravenous 49 postmarket studies 48 PMA submission 48 Targretin capsules 48 Biologic License Application BLA 48 prescribe Seroquel 48 EGRIFTA TM 48 CIP ISOTRETINOIN 48 OTC ZEGERID 48 devicemakers 47 Metricath Gemini 47 liver resection surgeries 47 Thorough QT studies 47 Certican 47 approvable letters 47 TQT study 47 User Fee Act 47 ATryn ® 47 Menaflex implant 47 SILENOR 47 Marketing Authorization Applications 47 BioSTAR R 47 IVDs 47 paliperidone palmitate 46 Cerashield TM 46 fusion enhancers 46 biologic DMARDs 46 Synerx 46 guideline concordant 46 Subpart H 46 erythropoietin stimulating agents 46 ULTRASE 46 sNDAs 46 FACTIVE tablets 46 thorough QT 46 GnRH agonists 46 Bioequivalence 46 Cellegesic 46 GRALISE 46 Spectranetics laser 46 BLAs 46 PD2i Analyzer TM 46 SYCREST 46 INDs 45 recombinant biopharmaceutical 45 Irinotecan Hydrochloride Injection 45 Expedited Review 45 transgenically produced product 45 DMEPOS supplier 45 RIGScan CR 45 eCTD format 45 balsalazide tablet 45 sNDA filing 45 HepaGam B 45 NDAs 45 Aplenzin 45 Trobalt 45 Linjeta TM 45 OvaRex ® MAb 45 Sutent sunitinib 45 Vimpat R 45 Tarceva TM 45 Plenaxis R 45 lipid lowering agents 45 CDSCO 45 Market Approval PMA 45 EDQM 45 adjunctively 45 LCPs 45 Retacrit 45 molecular entities NMEs 45 THALOMID 45 HCPCS code 45 indiplon capsules 45 faropenem 45 PMPRB 44 treat enlarged prostate 44 Notified Bodies 44 oral anticoagulation 44 GTC recombinant human 44 Visian Toric ICL 44 Zavesca r 44 QOPI 44 RCTs 44 Rasilez HCT 44 SEASONALE 44 glycoprotein IIb IIIa inhibitors 44 Biophan patent 44 randomized controlled trials RCTs 44 clinical trials 44 Tekturna Rasilez 44 granted Ortec 44 Tumor Response 44 Captisol ® 44 Evoltra ® 44 generic biologic 44 superficial dermatological procedures 44 UVIDEM 44 WHO prequalification 44 TWYNSTA ® 44 CORTOSS Bone Augmentation Material 44 pacemakers ICDs 44 Cetirizine Hydrochloride Syrup 44 infant formula contaminant 44 Keppra XR 44 ANDAs pending approval 44 FDAs 44 Kombiglyze XR 44 Doxycycline Tablets 44 recombinant antithrombin product 44 ß blockers 44 Intermezzo ® NDA 44 SOLODYN 44 FIRAZYR 43 DCGI 43 APRNs 43 BRILINTA 43 MGCD# clinical trials 43 sNDA submission 43 topical NSAIDs 43 EGRIFTA ™ 43 NCCN guidelines 43 Pre IND 43 MethyPatch 43 Emselex 43 antiepileptics 43 COIs 43 BLA filing 43 k Premarket Notification 43 biogeneric drugs 43 transcervical sterilization 43 certificants 43 Erythropoiesis Stimulating Agents ESAs 43 GLP toxicology studies 43 requiring Asthmatx 43 TWGs 43 gainsharing 43 generic biopharmaceuticals 43 biventricular pacemakers 43 Flutiform TM 43 CIP TRAMADOL ER 43 PROMACTA CARES 43 BiDil XR 43 Dalbavancin 43 NATRECOR ® 43 Competent Authorities 43 Angiomax bivalirudin 43 Investigational Device Exemption 43 oncological outcomes 43 NDA BLA 43 propoxyphene containing 43 ANDA filings 43 Biologics Licensing 43 Phase lll 43 Solesta 43 darifenacin 43 Nascobal 43 Somatuline R Autogel R 43 Accelerated Approval 42 pharmacoeconomic 42 constipation OIC 42 Hexvix 42 MyVax 42 Biologics License Applications 42 BLA submission 42 Lofexidine 42 CLIA waiver 42 PDUFA reauthorization 42 CMOS foundries 42 alogliptin 42 PROCAPS 42 antiplatelet medications 42 RDs 42 authority Gurian Sherman 42 Junovan 42 thrombolytic agents 42 Phase III LibiGel 42 cobas HPV Test 42 Marketing Authorisation 42 SURFAXIN 42 ORBIT II 42 Daytrana ™ 42 ENRICH trial 42 Civacir 42 ARIXTRA R 42 ICMJE 42 concomitant medications 42 Voraxaze 42 Glassia 42 Metformin GR 42 Kaletra tablet 42 cohesive gel implants 42 Reloxin ® 42 CGMs 42 India DCGI 42 Applications ANDA 42 Zevalin consolidation 42 BPS IC 42 Rotarix R 42 Berinert 42 LUVOX CR 42 DIABECELL ® 42 PROVIGIL 42 Pemetrexed 42 Periostat 42 NerPharMa 42 InterfeRx 42 Percutaneous Coronary Interventions 42 Ceragenin 42 Morphine Sulfate 42 ANDA submission 42 Systemic Lupus Erythematosus SLE 41 cGMP manufacture 41 FCC PTCRB 41 ZEFTERA ™ 41 Japanese MHLW 41 inferential statistics 41 eribulin mesylate 41 Teysuno 41 HCPs 41 Centralized Procedure 41 Acthar Gel 41 Metformin Hydrochloride 41 coronary revascularization 41 external beam radiotherapy 41 biogeneric 41 Preotact 41 SPAs 41 Max Neeman 41 Mimpara 41 Ceplene histamine dihydrochloride 41 bio similars 41 successfully commercialize Iluvien 41 Metoprolol Succinate 41 PIX# trial 41 ANDAs pending 41 TRISENOX 41 lipid lowering medications 41 symptomatic hyponatremia 41 FDAAA 41 Argatroban 41 inhaled bronchodilators 41 Submits Response 41 ruxolitinib 41 Recommended Practices 41 UL CSA 41 HBV vaccination 41 KRYSTEXXA TM 41 OVATION Pharmaceuticals 41 anticoagulation therapy 41 precertification 41 Oracea ® 41 arsenic trioxide ATO 41 methodologically rigorous 41 PLAVIX ® 41 biosimilar filgrastim 41 iDMS 41 Orphan Designation 41 DMEPOS suppliers 41 Q#IR 41 OMAPRO 41 immunosuppressives 41 HepeX B 41 gastrointestinal endoscopic 41 sublingual tablets 41 DXA scan 41 NeoVisc 41 CryoSeal FS System 41 hypogonadal men 41 Adenuric R 41 DTAB 41 Entereg TM 41 urodynamic parameters 41 Devices Agency PMDA 41 investigational medicinal 41 BioThrax ® 41 ODBA 41 AF ablation 41 Kerastick 41 Flutiform ™ 41 Somatuline Depot 41 UL certifications 41 gynecologic procedures 41 refractive surgical 41 Aphthasol R 41 intensive lipid lowering 41 pulls Darvon painkiller 41 PD2i Cardiac Analyzer 41 MAXY alpha 41 renal transplants 40 injectable contraceptives 40 Arzerra ofatumumab 40 daily Glumetza TM 40 Alternans 40 NESINA 40 antidiabetic medications 40 acetabular components 40 5 lipoxygenase inhibitor 40 MONOVISC 40 MEPACT 40 VATS lobectomy 40 mesylate tablets approved 40 ICH GCP 40 Orphan Status 40 LUMIGAN R 40 Vantas 40 VIPPS accreditation 40 Amlodipine Besylate Tablets 40 podiatric physicians 40 HSDD 40 surgeons radiologists 40 FDA Modernization Act 40 Sanofi Acomplia 40 BEXXAR therapeutic regimen 40 Gestiva TM 40 CDISC ODM 40 LXI compliant 40 pediatric exclusivity 40 osteopathic manipulative treatment 40 Ceragenin ™ technology 40 lipid lowering drugs 40 SILENOR ™ 40 SFIs 40 CT urography 40 OMAPRO ™ 40 DMFs 40 Exorbitant salaries 40 injection lipolysis 40 cefuroxime axetil 40 Methylphenidate Transdermal System 40 dalbavancin 40 abatacept 40 octagam ® 40 vinorelbine emulsion 40 proton MR spectroscopy 40 European Pharmacopoeia 40 STCs 40 CRINONE 8 40 generic Copaxone 40 Glucomed 40 Contrave NDA 40 CADs 40 oral hypoglycemic agents 40 Formularies 40 Raptiva R 40 SPARLON 40 Marketing Authorisations 40 NHPs 40 Bioaccelerate compounds under 40 opioid mediated 40 preapproval 40 ENLIGHT 40 BioThrax R 40 iii Cubist 40 Zelnorm Zelmac 40 Taxol r 40 SNT MC# 40 MAAs 40 MHLW 40 ICD therapy 39 Fanapt ® 39 Bonefos 39 Toraymyxin ™ 39 QAB# 39 pixantrone NDA 39 generic Lovenox 39 Subgroup analyzes 39 symptomatic fibroids 39 Active Pharmaceutical Ingredient 39 EN ISO # 39 GCF certification 39 Australian Therapeutic Goods 39 Clinical Trials Directive 39 prasterone 39 Pfizer maraviroc 39 Juvederm Ultra 39 Reclast Aclasta 39 Pennsaid Plus 39 Tracleer r 39 MRAs 39 Approvable 39 tramiprosate ALZHEMED TM 39 supplies DMEPOS 39 Megace R ES 39 #D#C# 39 podiatric medical 39 Topiramate tablets 39 coronary revascularization procedures 39 Phase IIa clinical trials 39 Monovisc 39 venous thromboembolism prophylaxis 39 Loramyc R 39 standardizations 39 SFDA approval 39 supplemental Biologics License Application 39 AFSSAPS 39 EvaMist NDA submission 39 somatoform disorders 39 GRAS determination 39 IND submission 39 generic Valtrex 39 ICH GCP guidelines 39 CHAMPVA 39 ICD implantations 39 Product Characteristics 39 pelvic lymphadenectomy 39 MorphoSys proprietary 39 GEM #S 39 Unifill syringe 39 Rheumatologists 39 subprograms 39 FDA Accelerated Approval 39 CE Marking 39 successfully commercialize Silenor 39 Angiox 39 actuarially equivalent 39 QFNs 39 TEMODAL 39 Increlex R 39 Albain Winer 39 HoLEP 39 Forsteo 39 ZEFTERA TM Zevtera TM 39 orally bioavailable compound 39 TACLONEX 39 ONGLYZA ™ 39 RoACTEMRA 39 Thelin TM 39 TNF alpha blockers 39 Subpart E 39 SNOMED CT 39 ANDA approvals 39 Corail Hip System 39 Class IIb 39 Reloxin R 39 CHMP recommendation 39 GRAS affirmation 39 aromatase inhibitors AIs 39 www.soliris.net 39 FEDVIP 39 Allopathy 39 TRANSDUR Bupivacaine 39 Mediabox PA 39 ANDA abbreviated 39 Stavzor 39 perfusion abnormalities 39 DAAs 39 oral hypoglycemic agent 39 Severe Primary IGFD 38 Aloxi Injection 38 thromboprophylaxis 38 Actimmune R 38 nonphysicians 38 directive #/#/EC [002] 38 MPRs 38 Biologic License Application 38 ONTAK 38 Orathecin 38 SparVax 38 urologic surgeons 38 tocilizumab 38 Attrius TM PET 38 exclusivities 38 Sunesis clinical trials 38 % CI #.#-#.# [005] 38 Multicenter Automatic Defibrillator Implantation 38 IRESSA 38 postprocedure 38 CoPP 38 Marketing Authorisation Application 38 Lantheus imaging 38 Thalidomide Pharmion 38 HSCR 38 oral antidiabetes drugs 38 ANVISA 38 CoC accredited 38 Ceragenin TM technology 38 Elitek 38 ACTILON 38 professional licensures 38 Marketing Authorisation Application MAA 38 SMOs 38 Joulferon 38 USFDA 38 orphan designation 38 IND Investigational New 38 ISSMP 38 CIPI 38 Schematic Design 38 Ranolazine 38 generic atorvastatin 38 GLASSIA ™ 38 Exelbine NDA 38 pharmacological therapies 38 Exelbine 38 Certificate STC 38 Orphan designation 38 Angioplasties 38 Multiferon R 38 EU RoHS Directive 38 SIMPONI TM golimumab 38 lipid lowering medication 38 aripiprazole 38 NCEP ATP III 38 Increlex TM 38 CNMs 38 FOSHU 38 Orphan Drug designations 38 nondrug treatments 38 ZEGERID Chewable Tablets 38 Receives Tentative FDA 38 SuperStitch ® 38 UGC AICTE 38 perioperative nurses 38 Metabasis stockholders 38 Loramyc ® 38 IPTs 38 lorcaserin NDA 38 Orphan Drug Status 38 DFAR 38 vemurafenib 38 iChem VELOCITY 38 Biological License Application 38 Cialis dosage 38 NADCAP 38 Marketing Authorization Application 38 autologous chondrocyte implantation 38 Nonclinical 38 KDOQI 38 Aflunov 38 SCAs 38 WDEQ 38 SSRI SNRI 38 Exemption TUE 38 Directorate TPD 38 Sertraline Hydrochloride Tablets 38 Decentralized Procedure 38 CLIA Waiver 38 ISIPublisher 38 duplexers 38 commercialized DURECT 37 recombinant FSH 37 Mitigation Strategy 37 APTIVUS ritonavir 37 PER.C6 r 37 DRX# ™ 37 QTc intervals 37 Fast Track Status 37 diovan 37 unani 37 Poly ICR 37 Naturopathic doctors 37 Severe hypersensitivity reactions 37 inguinal hernia repair 37 VaxImmune 37 airworthiness certification 37 Tender Documents 37 Encysive Pharmaceuticals Nasdaq ENCY 37 Solazed 37 silicon micromachined 37 Teflaro 37 nephron sparing surgery 37 GRAS designation 37 WiMAX Forum certification 37 Marketing Authorizations 37 BENLYSTA 37 OLpur TM H2H 37 Combined License Application 37 quinolone 37 Concurso Plan 37 depot antipsychotics 37 sumatriptan succinate tablets 37 Rhucin ® 37 newer antipsychotic medications 37 tramadol HCl 37 arecurrently 37 Fast Track designations 37 Ayurvedic Unani 37 total knee arthroplasties 37 FoodChek ™ E 37 Priyank Bharti 37 authorizations 37 DSAs 37 MYLOTARG 37 Pneumococcal vaccination 37 Grünenthal 37 Afresa 37 Tamoxifen Citrate 37 Fanapt ™ 37 noncardiovascular mortality 37 OraDisc TM 37 Mammography Quality 37 CRLs 37 RMTs 37 Junovan TM 37 risk reducing salpingo 37 JAR OPS 37 cataract extraction 37 glitazones 37 RPSs 37 CPAPs 37 Accelerating apoptosis may 37 compounded bioidentical hormones 37 nonphysician 37 PTCRB certification 37 ICLs 37 IPMs 37 Proquin 37 epidural steroid injection 37 Eat Drink Snack 37 Lipsovir ® 37 Interpretative Communication 37 LPCs 37 tamsulosin hydrochloride capsules 37 SMBG 37 clopidogrel pretreatment 37 polyarticular 37 Impax ANDA 37 pharmacological treatments 37 psychometrically sound 37 methodological limitations 37 Dexo 37 Zensana 37 DVCs 37 Daytrana TM 37 SEBIVO 37 von Eschenbach nomination 37 received CE Conformite 37 preparticipation screening 37 anti arrhythmic drugs 37 diagnosable mental disorders 37 GHTF 37 GRAS notification 37 Surfaxin lucinactant 37 cognitive behavioral therapies 37 poor metabolizers 37 CVDs 37 CELVAPAN H#N# 37 bilastine 37 Pharmacopoeia USP 37 Randall Lutter Ph.D. 37 psychotherapeutic interventions 37 gynecology paediatrics 37 Pillar5 37 neuroradiologists 37 Japanese Encephalitis Vaccine 37 ICSI cycles 37 NIJ .# 37 postexposure prophylaxis 37 Administration TGA 37 Swissmedic 37 BfArM 37 intraclass correlation coefficients 37 Scientific Advice 37 FPCs 37 Marketing Authorization 37 Tostrex 37 Use Authorization EUA 37 NCT# ClinicalTrials.gov 37 NOPR 37 oncologic outcomes 37 orphan medicinal 37 Dificid 37 GnRH agonist 37 Company LUMA imaging 37 PRPPs 37 workplans 37 IND CTA 37 eprodisate KIACTA TM 37 cethromycin NDA 37 Xyotax 37 immunosuppressive medications 37 ANDAs abbreviated 37 Testim 36 Generic medicines 36 Zanaflex tablets 36 IMRT IGRT 36 SWHCS 36 AstraZeneca Toprol 36 promote ceftobiprole 36 Esbriet pirfenidone 36 MS DRG 36 Surgical Procedures 36 LOPROX R 36 endoscopists 36 lender consents 36 R sipuleucel T 36 licensures 36 Testosterone deficiency 36 JOULFERON 36 PRDs 36 LOAs 36 Barr ANDA 36 Common Criteria certifications 36 Physician Fee 36 sBLA 36 Tamiflu oseltamivir phosphate 36 Replagal 36 telavancin NDA 36 BPH LUTS 36 Marketing Approval PMA 36 Acetavance TM 36 Intel IBIST 36 unruptured aneurysm 36 Image Guided Surgery 36 Hatch Waxman Amendments 36 Urodynamics 36 Common Criteria CC 36 HHAs 36 antimuscarinic 36 psychopharmacological 36 DPIs 36 CANopen interface 36 EQ 5D 36 Allopathic 36 antiviral regimens 36 Vibativ 36 Complete Response letter 36 antiandrogens 36 QAB# indacaterol 36 PCWP 36 Loramyc ™ 36 AECB 36 Ivax Teva 36 NPIs 36 intermittent pneumatic 36 EUROCAE 36 Appendix VII 36 Orphan Drug status 36 IEED 36 Lubiprostone 36 THELIN 36 SEIs 36 lipoprotein lipase deficiency LPLD 36 severe dermatologic toxicities 36 HITECH provisions 36 Artificial Cornea 36 Approvable Letter 36 Gleevec Glivec 36 chronic prostatitis chronic 36 APMA Seal 36 Application BLA 36 XAGRID 36 NAND NOR 36 APLs 36 knee arthroscopies prostate biopsies 36 Evoltra 36 atherosclerotic renal artery stenosis 36 inspectional observations 36 symptomatic DVT 36 LTCHs 36 Enabling Clause 36 NIPER 36 nurse prescribers 36 LVDS interfaces 36 USFDA approval 36 Evoltra R 36 www.fda.gov MedWatch 36 nurse practitioner NP 36 Drug Administration USFDA 36 primary aldosteronism 36 metastatic RCC 36 intersessional meetings 36 Pharmos pipeline 36 IMHA 36 Drug Applications sNDAs 36 CMPs 36 supplemental biologics 36 rhinoplasty liposuction 36 poststroke depression 36 Galephar 36 GVAX Prostate 36 malabsorptive 36 needleless connectors 36 MDMs 36 AICTE norms 36 blinded randomized controlled 36 atherothrombotic disease 36 documentation evidencing 35 studies evaluating satraplatin 35 INVOS 35 Non inferiority 35 percutaneous transluminal coronary angioplasty 35 Adenuric ® 35 gluteal injection 35 chelation therapies 35 incorporate CXA 35 Filgrastim 35 ANDA 35 NETGEAR Powerline AV 35 Rhucin R 35 appli cations 35 Biologics License Application 35 spinal manipulations 35 Vitaros 35 PROLACRIA ™ 35 nonfederal entities 35 macrolide antibiotics 35 atypical antipsychotic medications 35 USDA FSIS 35 prenatal multivitamin 35 Lovaza TM 35 Excellent Accreditation status 35 CAGE Code 35 BEMA Granisetron 35 #mb PowerBook G4 35 functional gastrointestinal disorders 35 ALT flares 35 unapplied 35 Directive #/#/EEC [001] 35 FASTx TM 35 Competent Authority 35 qualification questionnaire PQQ 35 European Medicines Agency 35 arthritis psoriasis 35 androgen deprivation 35 extensive metabolizers 35 prescribe medicines 35 EtherProbe 35 endocrine therapies 35 Grants Orphan Drug 35 RF MEMS switches 35 Menarini Group 35 InSight Publisher 35 oBIX 35 enrolees 35 coronary intervention 35 interrater 35 CLCSS 35 PUs 35 IS# [004] 35 andsupport 35 self affirmed GRAS 35 Fluviral 35 Hyperbaric Oxygen Therapy HBOT 35 dysfunctional voiding 35 somatization disorder 35 venous thromboembolism VTE prophylaxis 35 genital HPV infections 35 Sumatriptan Succinate Tablets 35 retrospective cohort 35 TOSAs 35 logistic regression models 35 ICAVL 35 Entereg alvimopan 35 Shigamabs 35 colonoscopic 35 rolling Biologics License 35 nonpsychiatric 35 Medicinal Products EMEA 35 OCPs 35 Authorisations 35 Accelerated Assessment 35 JunJing III 35 Adenuric 35 daily bactericidal antibiotic 35 JN NURM 35 Novartis Galvus 35 Orphan Drug designation 35 LLLT 35 SCHWARZ PHARMA 35 expressly preempted 35 chemoradiation therapy 35 Remissions 35 Allovectin 7 r 35 diplomates 35 blood thinner prasugrel 35 Privacy Impact Assessments 35 IBS C 35 optical isolators 35 eGaN 35 Volunteer cosmetologists 35 Clinical Trial Application 35 Mutual Recognition Procedure 35 syndromal 35 Cabilly patent 35 comorbid conditions 35 lymphadenectomy 35 gas chromatographs 35 WGs 35 VLSI CAD 35 National Qualifications Framework 35 laparoscopic technique 35 MHPAEA 35 PSRs 35 DMEPOS 35 nonsurgical treatments 35 late onset hypogonadism 35 ADDERALL XR R 35 Chronic Constipation 35 multivariate analyzes 35 pharmacological approaches 35 Percutaneous Coronary Intervention 35 QOF indicators 35 Testosterone Replacement Therapy 35 PET CT scanning 35 epidural analgesia 35 BSCs 35 Incandescent Lamps 35 varicoceles 35 DPMs 35 cerebral microbleeds 34 Ipsen botulinum toxin 34 Bioxel 34 coexisting illnesses 34 Official canadian pharmacy 34 + enantiomer 34 CAHs 34 pessary 34 triglyceride concentrations 34 comorbid diagnoses 34 Follow Vishay 34 OTDRs 34 APOE genotype 34 SOs 34 Fast Track Designation 34 Proposed Arrangement 34 Etanercept 34 initiate roving wiretaps 34 approvals 34 Dr YK Gupta 34 DUs 34 Simplified Acquisition 34 SAS expanders 34 assigned PDUFA 34 Governing Councils 34 surgical facial rejuvenation 34 Fast Track designation 34 PBAs 34 Therapeutic Goods Administration TGA 34 Regional Coordinating Councils 34 idursulfase 34 Paonta Sahib plant 34 conformity assessment 34 Medicaid RACs 34 Cladribine Tablets 34 SiPs 34 standardization 34 Antiretroviral Therapy ART 34 Pilanesberg Project 34 Competence Assurance 34 intracranial hemorrhage ICH 34 mercury amalgam 34 SPMs 34 ANMs 34 EnerBurn R 34 ANDA filer 34 logistic regression analyzes 34 BSMS 34 comorbid disorders 34 Dr. Kauvar 34 biosimilar medicines 34 reportability 34 EQF 34 gave Makena orphan 34 tamper resistant pads 34 RARS 34 ColonSentry test 34 taliglucerase alfa 34 ABIM 34 PMBs 34 TORs 34 LUTS 34 PCPs 34 cytoreductive nephrectomy 34 hyperuricaemia 34 missy fit 34 pulmonary hypertension PH 34 Investigational Medicinal Product 34 decellularized 34 F#x [001] 34 Dermal Filler 34 post thrombotic syndrome 34 Kyowa Kirin 34 EACs 34 viii inability 34 transfusional iron overload 34 PBOR 34 nonelective 34 Longitudinal studies 34 Meda STO MEDAA 34 MRs 34 EBx ® 34 Zidovudine Tablets 34 colorectal carcinomas 34 densitometry 34 Cheaper Medicines Bill 34 uk domains 34 MSIs 34 SOFAs 34 AFAs 34 securityholder approvals 34 DYNACIN R Tablets 34 Avoid jalapenos